- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterThursday, November 3, 2005
OncoLink's daily online reports from the Chemotherapy Foundation Symposium in New York City on November 2-5, 2005. |
|
Experience with ABI-007 (Abraxane) in Head and Neck Cancers
ABI-007 (brand name Abraxane™) is a protein-bound form of the popular chemotherapy drug paclitaxel (brand name Taxol®)). Standard paclitaxel is formulated with ethanol and a substance called Cremophor EL (polyoxyethylated... |
|
|
Ixabepilone in Breast Cancer
Presenter: Sandra M. Swain, MDPresenter's Affiliation: National Cancer InstituteType of Session: ScientificBackground Microtubules are formed from a protein called tubulin. Microtubules form the skeleton of cells, and have to be... |
|
|
Panitumumab, A Fully-Human IgG2 Antibody Treatment for Colorectal Cancer
Overexpression of epidermal growth factor receptor (EGFR) is seen in many human malignancies, including colorectal cancer. The cellular pathways that are triggered by EGFR activation are involved in cell growth and proliferation. ... |
|
|
Preoperative Therapy with Trastuzumab
Presenter: Eric P. Winer, MDPresenter's Affiliation: Dana Farber Cancer Institute, Boston, MAType of Session: ScientificBackground The NSABP B-18 trial randomized women with locally advanced breast cancers to receive either preoperative... |
|
|
Role of Ras Inhibitors in the Management of Breast Cancer
Presenter: Joseph A. Sparano, MDPresenter's Affiliation: Albert Einstein Cancer Center, Bronx, New YorkType of Session: ScientificBackground G proteins are a superfamily of >100 proteins which are widely distributed in mammalian cells. ... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
